查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458033

全球類器官和球體市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Organoids And Spheroids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

全球類器官和球體市場的需求預計將從 2023 年的 780.92 萬美元達到 2032 年的近 5,444.06 萬美元，在 2024 年至 2032 年的研究期間CAGR為 24.08%。

類器官和球體是3D細胞培養物，可模仿實驗室環境中器官或組織的結構和功能。類器官是自組織的微型器官，而球體是具有球形形狀的細胞聚集體。這些模型用於生物醫學研究，以研究器官發育、疾病進展和藥物測試。它們比傳統細胞培養物更準確地表示體內條件，提供對複雜生物過程的見解並支持個人化醫療的進步。

市場動態

類器官和球體市場是由再生醫學、藥物發現和個人化醫療的進步以及利用3D (3D) 細胞培養技術推動的。生物醫學研究、藥物篩選和疾病建模中對更多生理相關模型的需求促進了市場成長。這些 3D 細胞培養系統具有重現組織特異性功能、模擬複雜相互作用以及更接近反映體內條件的潛力，推動了它們在生命科學和製藥行業的採用。此外，對減少對動物模型的依賴和對個人化治療方法的需求的關注推動了類器官和球體的開發和利用。技術創新，包括生物製造技術以及先進成像和分析工具的整合，進一步支持類器官和球體在生物醫學研究和治療開發中的擴大應用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球類器官和球體市場的每個細分市場進行了包容性評估。類器官和球體產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

類器官和球體市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 類器官（類型（神經類器官、肝類器官、腸類器官、其他類器官）、方法（類器官培養的一般浸沒法、隱窩類器官培養技術、類器官培養的氣液界面(Ali) 方法、來自Lgr5+ 細胞的克隆類器官、腦和視網膜類器官形成方案，其他），來源（原代組織，幹細胞）
  • 球體（類型（多細胞腫瘤球體 (Mcts)、神經球、乳腺球、肝球、胚狀體）、方法（微圖案板、低細胞附著板、懸滴法、其他）、來源（細胞株、​​原代細胞、Ipscs 衍生細胞）

按申請

  • 發育生物學
  • 個人化醫療
  • 再生醫學
  • 疾病病理學研究
  • 藥毒及功效測試

按最終用途

  • 生物技術和製藥業
  • 學術及研究機構
  • 醫院和診斷中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲類器官和球體市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

  • 按地區分類的全球類器官和球體市場佔有率（代表性圖）
  • 全球類器官和球體市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。類器官和球體市場的主要參與者包括 3D Biomatrix、3D Biotek LLC、AMS Biotechnology (Europe) Limited、Cellesce Ltd、康寧公司、Greiner Bio-One、Hubrecisht Organoid Technology (HUB)、InSphero、Lonza、Merck KGaA、Precisht Organoid Technology (HUB)、InSphero、Lonza、Merck KGaA、Precisht 有機體生物製劑、STEMCELL Technologies Inc.、Thermo Fisher Scientific, Inc.。本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：類器官與球體 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球類器官和球體市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 類器官（類型（神經類器官、肝類器官、腸類器官、其他類器官）、方法（類器官培養的一般浸沒法、隱窩類器官培養技術、類器官培養的氣液界面(Ali) 方法、來自Lgr5+ 細胞的克隆類器官、腦和視網膜類器官形成方案，其他），來源（原代組織，幹細胞）
  • 球體（類型（多細胞腫瘤球體 (Mcts)、神經球、乳腺球、肝球、胚狀體）、方法（微圖案板、低細胞附著板、懸滴法、其他）、來源（細胞株、​​原代細胞、Ipscs 衍生細胞）

第 6 章：全球類器官與球體市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 發育生物學
  • 個人化醫療
  • 再生醫學
  • 疾病病理學研究
  • 藥毒及功效測試

第 7 章：全球類器官與球體市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 生物技術和製藥業
  • 學術及研究機構
  • 醫院和診斷中心

第 8 章：全球類器官與球體市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：類器官與球體公司的競爭格局

  • 類器官和球體市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • 3D Biomatrix
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • 3D Biotek LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AMS Biotechnology (Europe) Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cellesce Ltd
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Corning Incorporated
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Greiner Bio-One
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Hubrecht Organoid Technology (HUB)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • InSphero
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lonza
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Prellis Biologics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • STEMCELL Technologies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113863

The global demand for Organoids And Spheroids Market is presumed to reach the market size of nearly USD 5444.06 MN by 2032 from USD 780.92 MN in 2023 with a CAGR of 24.08% under the study period 2024 - 2032.

Organoids and spheroids are three-dimensional cell cultures that mimic the structure & function of organs or tissues in a laboratory setting. Organoids are self-organized, miniature versions of organs, while spheroids are cell aggregates with spherical shapes. These models are used in biomedical research to study organ development, disease progression, and drug testing. They provide more accurate representations of in vivo conditions than traditional cell cultures, offering insights into complex biological processes and supporting advancements in personalized medicine.

MARKET DYNAMICS

The organoids and spheroids market is driven by advancements in regenerative medicine, drug discovery, and personalized medicine, leveraging three-dimensional (3D) cell culture technologies. The demand for more physiologically relevant models in biomedical research, drug screening, and disease modeling contributes market growth. The potential of these 3D cell culture systems to recapitulate tissue-specific functions, simulate complex interactions, and offer a closer representation of in vivo conditions fuels their adoption in the life sciences and pharmaceutical industries. Additionally, the focus on reducing reliance on animal models and the need for personalized treatment approaches drive the development and utilization of organoids and spheroids. Technological innovations, including biofabrication techniques and the integration of advanced imaging and analysis tools, further support the expanding applications of organoids and spheroids in biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organoids and spheroids. The growth and trends of organoids and spheroids industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organoids and spheroids market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells)

By Application

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

By End-Use

  • Biotechnology And Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals And Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organoids And Spheroids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Organoids And Spheroids Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organoids And Spheroids market include 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Cellesce Ltd, Corning Incorporated, Greiner Bio-One, Hubrecht Organoid Technology (HUB), InSphero, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc., Thermo Fisher Scientific, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORGANOIDS AND SPHEROIDS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Historic and Forecast Sales by Regions
  • 5.5 Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Historic and Forecast Sales by Regions

6 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Developmental Biology Historic and Forecast Sales by Regions
  • 6.5 Personalized Medicine Historic and Forecast Sales by Regions
  • 6.6 Regenerative Medicine Historic and Forecast Sales by Regions
  • 6.7 Disease Pathology Studies Historic and Forecast Sales by Regions
  • 6.8 Drug Toxicity & Efficacy Testing Historic and Forecast Sales by Regions

7 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Biotechnology and Pharmaceutical Industries Historic and Forecast Sales by Regions
  • 7.5 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 7.6 Hospitals and Diagnostic Centers Historic and Forecast Sales by Regions

8 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGANOIDS AND SPHEROIDS COMPANIES

  • 9.1. Organoids And Spheroids Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ORGANOIDS AND SPHEROIDS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 3D Biomatrix
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. 3D Biotek LLC
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. AMS Biotechnology (Europe) Limited
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Cellesce Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Corning Incorporated
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Greiner Bio-One
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Hubrecht Organoid Technology (HUB)
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. InSphero
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Lonza
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Merck KGaA
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Prellis Biologics
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. STEMCELL Technologies Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Thermo Fisher Scientific Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Market Sales by Geography (USD MN)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Developmental Biology Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Disease Pathology Studies Market Sales by Geography (USD MN)
  • Drug Toxicity & Efficacy Testing Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Biotechnology and Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Hospitals and Diagnostic Centers Market Sales by Geography (USD MN)
  • Global Organoids And Spheroids Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Organoids And Spheroids Report
  • Market Research Process
  • Market Research Methodology
  • Global Organoids And Spheroids Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Market Sales by Geography (USD MN)
  • Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Developmental Biology Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Disease Pathology Studies Market Sales by Geography (USD MN)
  • Drug Toxicity & Efficacy Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biotechnology and Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Hospitals and Diagnostic Centers Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.